<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>医药魔方 | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2020-11-09T11:23:55+08:00</updated>
  <subtitle>世事洞明皆学问，人情练达即文章</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>ADC领军企业荣昌生物今日挂牌上市！8万升大分子产能蓄势待发</title>
    <updated>2020-11-09T07:50:52+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-09:/s/N-n2TTC6dWYjJLOwuKXU5A</id>
    <link href="https://mp.weixin.qq.com/s/N-n2TTC6dWYjJLOwuKXU5A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>挑战胰腺癌，新款ADC药物来了！</title>
    <updated>2020-11-09T07:50:52+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-09:/s/F-j8dzYxBMvYy55Sej7gkw</id>
    <link href="https://mp.weixin.qq.com/s/F-j8dzYxBMvYy55Sej7gkw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>BD课程 | 研发阶段的项目交易</title>
    <updated>2020-11-09T07:50:52+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-09:/s/CyIaNg9Id1kF7N6tsZK9xg</id>
    <link href="https://mp.weixin.qq.com/s/CyIaNg9Id1kF7N6tsZK9xg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>Nature：中国肿瘤药创新趋势</title>
    <updated>2020-11-08T08:19:34+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-08:/s/tZ6OxsUX2A2Owz8Cxll7Jw</id>
    <link href="https://mp.weixin.qq.com/s/tZ6OxsUX2A2Owz8Cxll7Jw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>中国糖尿病患者一定要警惕这种心血管疾病！患病率远超全球！</title>
    <updated>2020-11-07T07:56:54+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-07:/s/VfGr6WiPj8MDF6mbA05o_g</id>
    <link href="https://mp.weixin.qq.com/s/VfGr6WiPj8MDF6mbA05o_g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>赛默飞携手健新原力在华成立生物原液及无菌制剂制造工厂</title>
    <updated>2020-11-07T07:56:54+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-07:/s/pmmTnVwQEfGtEz-SwQMnmQ</id>
    <link href="https://mp.weixin.qq.com/s/pmmTnVwQEfGtEz-SwQMnmQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>全面升级 | 市场准入策略及证据的产生</title>
    <updated>2020-11-07T07:56:54+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-07:/s/B8ZeEK0hhsOAeAKCM3-wlw</id>
    <link href="https://mp.weixin.qq.com/s/B8ZeEK0hhsOAeAKCM3-wlw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>深耕中国市场26载！罗氏携6款创新药产品闪耀进博舞台</title>
    <updated>2020-11-06T16:28:00+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-06:/s/J94LL9IEKkyuTcLkhYbw7A</id>
    <link href="https://mp.weixin.qq.com/s/J94LL9IEKkyuTcLkhYbw7A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>临床研究月报 | 2020年10月</title>
    <updated>2020-11-06T16:28:00+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-06:/s/l1RsbPajQe-i8smwPxpfHw</id>
    <link href="https://mp.weixin.qq.com/s/l1RsbPajQe-i8smwPxpfHw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>医药魔方招聘：数据分析师（疫苗方向）</title>
    <updated>2020-11-06T16:28:00+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-06:/s/G6gf31IRfcACLoFIMY5-qA</id>
    <link href="https://mp.weixin.qq.com/s/G6gf31IRfcACLoFIMY5-qA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>实体肿瘤新突破！Selinexor用于脂肪肉瘤III期临床研究达到主要终点</title>
    <updated>2020-11-06T16:28:00+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-06:/s/klyWipUV0ws6kDmUg_hZkg</id>
    <link href="https://mp.weixin.qq.com/s/klyWipUV0ws6kDmUg_hZkg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>愈磐生物创始人钱锋/寇翔：刹那抉择，不过是有意无意的经年积累</title>
    <updated>2020-11-05T07:41:36+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-05:/s/zXvKjs-NNP2NTph9syN0pA</id>
    <link href="https://mp.weixin.qq.com/s/zXvKjs-NNP2NTph9syN0pA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>总资助3.28亿美元！CEPI与三叶草生物扩大合作，推进S-三聚体新冠疫苗临床开发及上市</title>
    <updated>2020-11-04T07:52:53+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-04:/s/BkULmtxzsmJVErRzeq759Q</id>
    <link href="https://mp.weixin.qq.com/s/BkULmtxzsmJVErRzeq759Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>先声药业管线中这个小分子，为何被FDA认定为突破性疗法？</title>
    <updated>2020-11-04T07:52:53+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-04:/s/NG6W8aV95yQMDMKefNv0dQ</id>
    <link href="https://mp.weixin.qq.com/s/NG6W8aV95yQMDMKefNv0dQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>医药魔方招聘： HEOR Senior Manager, Associate Director, Director</title>
    <updated>2020-11-04T07:52:53+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-04:/s/ilX2wiboAVUFkndGkb8EMQ</id>
    <link href="https://mp.weixin.qq.com/s/ilX2wiboAVUFkndGkb8EMQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>今年第10家！药明巨诺正式在港交所挂牌上市</title>
    <updated>2020-11-03T08:05:37+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-03:/s/PnUR8zteMx7cp4v8G9M1ug</id>
    <link href="https://mp.weixin.qq.com/s/PnUR8zteMx7cp4v8G9M1ug" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>攻关难治性肿瘤、精苛生物工艺，这一医药“黑马”能否缔造新神话？</title>
    <updated>2020-11-03T08:05:37+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-03:/s/UieH5YaK4Cv0hWcUX67DKg</id>
    <link href="https://mp.weixin.qq.com/s/UieH5YaK4Cv0hWcUX67DKg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>风云雄霸天下，晚期胃癌一线免疫治疗谁与争锋？</title>
    <updated>2020-11-03T08:05:37+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-03:/s/lMVgKb-88lC63cVLgasjqQ</id>
    <link href="https://mp.weixin.qq.com/s/lMVgKb-88lC63cVLgasjqQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>Biotech的新十年</title>
    <updated>2020-11-02T08:01:08+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-02:/s/0m1wsras6KQgi6i1RdhmnA</id>
    <link href="https://mp.weixin.qq.com/s/0m1wsras6KQgi6i1RdhmnA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>康方生物PD-1/VEGF双抗Ia期研究初步数据喜人：对PD-1不敏感型实体瘤患者效果良好</title>
    <updated>2020-11-02T08:01:08+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-02:/s/qOloSi5V93uNJUunMtyw0A</id>
    <link href="https://mp.weixin.qq.com/s/qOloSi5V93uNJUunMtyw0A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>